News

Net profit of Kilitch Drugs (India) rose 39.62% to Rs 14.52 crore in the quarter ended March 2026 as against Rs 10.40 crore during the previous quarter ended March 2025. Sales rose 46.33% to Rs 89.60 crore in the quarter ended March 2026 as against Rs 61.23 crore during the previous quarter ended March 2025.For the full year,net profit rose 13.00% to Rs 30.17 crore in the year ended March 2026 as against Rs 26.70 crore during the previous year ended March 2025. Sales rose 18.73% to Rs 235.47 crore in the year ended March 2026 as against Rs 198.32 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales89.6061.23 46 235.47198.32 19 OPM %24.7223.83 -15.5415.87 - PBDT21.1914.69 44 42.2837.58 13 PBT20.2113.84 46 38.6534.47 12 NP14.5210.40 40 30.1726.70 13 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 15 May 2026.

Kilitch Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 13 March 2026.Powered by Capital Market - Live News

Net profit of Kilitch Drugs (India) declined 25.67% to Rs 4.43 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. Sales declined 4.20% to Rs 53.81 crore in the quarter ended December 2025 as against Rs 56.17 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales53.8156.17 -4 OPM %11.4315.54 - PBDT6.539.06 -28 PBT5.608.25 -32 NP4.435.96 -26 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News